Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Deficit (Details) - Schedule of option activity

v3.22.1
Stockholders' Deficit (Details) - Schedule of option activity - Options [Member]
 3 Months Ended
Mar. 31, 2022
USD ($)
$ / shares
shares
Stockholders' Deficit (Details) - Schedule of option activity [Line Items]  
Option Number of Shares outstanding at beginning | shares 11,753,422
Option Weighted Average Exercise Price outstanding | $ / shares $ 0.36
Option Weighted Average Remaining Contractual Term outstanding at beginning 9 years 5 months 19 days
Option Aggregate Intrinsic Value outstanding at beginning | $ $ 196,825
Granted Number of Shares | shares
Granted Weighted Average Exercise Price | $ / shares
Granted Weighted Average Remaining Contractual Term
Granted Aggregate Intrinsic Value | $
Forfeited Number of Shares | shares
Forfeited Weighted Average Exercise Price | $ / shares
Forfeited Weighted Average Remaining Contractual Term
Forfeited Aggregate Intrinsic Value | $
Exercised Number of Shares | shares
Exercised Weighted Average Exercise Price | $ / shares
Exercised Weighted Average Remaining Contractual Term
Exercised Aggregate Intrinsic Value | $
Expired Number of Shares | shares
Expired Weighted Average Exercise Price | $ / shares
Expired Weighted Average Remaining Contractual Term
Expired Aggregate Intrinsic Value | $
Option Number of Shares outstanding at ending | shares 11,753,422
Option Weighted Average Exercise Price outstanding at ending | $ / shares $ 0.36
Option Weighted Average Remaining Contractual Term outstanding at ending 9 years 2 months 23 days
Option Aggregate Intrinsic Value outstanding at ending | $ $ 368,767
Option Number of Shares exercisable at ending | shares 7,878,665
Option Weighted Average Exercise Price exercisable at ending | $ / shares $ 0.43
Option Weighted Average Remaining Contractual Term exercisable at ending 9 years 7 days
Option Aggregate Intrinsic Value exercisable at ending | $ $ 94,007